Spearman correlations (RS) and 95% CI of calretinin and mesothelin assessed with assays approved for clinical diagnostics with age and blood parameters determined previously
| Calretinin ELISA (ng/mL) | Mesothelin CLEIA (nM) | Mesothelin ELISA (nM) | |
| rS (95% CI) | rS (95% CI) | rS (95% CI) | |
| Mesothelin CLEIA (nM) | 0.25 (0.18 to 0.33) | ||
| Mesothelin ELISA (nM) | 0.21 (0.13 to 0.29) | 0.93 (0.92 to 0.94) | |
| Age (years) | 0.21 (0.13 to 0.29) | 0.27 (0.20 to 0.35) | 0.24 (0.16 to 0.32) |
| C reactive protein (mg/dL) | 0.21 (0.13 to 0.29) | 0.10 (0.01 to 0.18) | 0.08 (0.00 to 0.16) |
| Fibrinogen (mg/dL) | 0.12 (0.04 to 0.20) | 0.08 (0.00 to 0.16) | 0.09 (0.01 to 0.17) |
| Cystatin C (mg/L) | 0.53 (0.46 to 0.58) | 0.33 (0.25 to 0.40) | 0.27 (0.20 to 0.35) |
| Creatinine (mg/dL) | 0.41 (0.34 to 0.47) | 0.28 (0.20 to 0.35) | 0.24 (0.17 to 0.32) |
| Brain natriuretic peptide (pg/mL) | 0.14 (0.06 to 0.22) | 0.06 (−0.02 to 0.14) | 0.06 (−0.03 to 0.14) |
| Haemoglobin, (g/L) | −1.3 (−0.21 to −0.05) | −0.80 (−0.16 to 0.00) | −0.70 (−0.15 to 0.01) |
| Red blood cells (×1012/L) | −0.10 (−0.19 to −0.02) | −0.11 (−0.19 to −0.02) | −0.10 (−0.18 to −0.02) |
| Haematocrit (L/L) | −0.12 (−0.20 to −0.03) | −0.04 (−0.12 to 0.04) | −0.05 (−0.13 to 0.03) |
| Triglycerides (mg/dL) | 0.19 (0.11 to 0.27) | 0.00 (−0.09 to 0.08) | −0.02 (−0.10 to 0.07) |
| Haemoglobin A1c (%) | 0.16 (0.08 to 0.24) | 0.03 (−0.06 to 0.11) | 0.01 (−0.07 to 0.10) |
Statistically significant results are marked in bold.
CLEIA, chemiluminescent enzyme immunoassay.